Literature DB >> 17688836

Advances in the immunopathophysiology of the idiopathic inflammatory myopathies: not as simple as suspected.

Gerald J D Hengstman1.   

Abstract

In the past three decades, not much has changed in the pathophysiologic concepts of dermatomyositis and polymyositis. However, in the past couple of years, many changes have occurred reflecting the extremely complex nature of the immune response in general. New pathophysiologic models are needed, but at present, none of them encompasses all the recent findings. The changing concepts of dermatomyositis and polymyositis offer new opportunities for unraveling these diseases and developing better strategies for prevention and treatment. This article discusses the most important developments and their methodologic short-comings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17688836     DOI: 10.1007/s11926-007-0045-7

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  49 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Evidence for heterogeneity of T cell expansion in polymyositis and inclusion body myositis.

Authors:  M F G van der Meulen; D F van Wichen; W T M van Blokland; L H van den Berg; J H J Wokke; J E Hoogendijk; R A de Weger
Journal:  J Neuroimmunol       Date:  2002-12       Impact factor: 3.478

3.  Myeloid dendritic cells in inclusion-body myositis and polymyositis.

Authors:  Steven A Greenberg; Geraldine S Pinkus; Anthony A Amato; Jack L Pinkus
Journal:  Muscle Nerve       Date:  2007-01       Impact factor: 3.217

Review 4.  Polymyositis, dermatomyositis and inclusion-body myositis.

Authors:  M C Dalakas
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

5.  Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells.

Authors:  K Nagaraju; N Raben; M L Villalba; C Danning; L A Loeffler; E Lee; N Tresser; A Abati; P Fetsch; P H Plotz
Journal:  Clin Immunol       Date:  1999-08       Impact factor: 3.969

6.  Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies.

Authors:  A M Emslie-Smith; K Arahata; A G Engel
Journal:  Hum Pathol       Date:  1989-03       Impact factor: 3.466

7.  Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.

Authors:  Dalia Dimitri; Olivier Benveniste; Odile Dubourg; Thierry Maisonobe; Bruno Eymard; Zahir Amoura; Laetitia Jean; Kiet Tiev; Jean-Charles Piette; David Klatzmann; Serge Herson; Olivier Boyer
Journal:  Brain       Date:  2006-02-02       Impact factor: 13.501

8.  T cell receptor beta-chain repertoire in inclusion body myositis.

Authors:  I M Fyhr; A R Moslemi; C Lindberg; A Oldfors
Journal:  J Neuroimmunol       Date:  1998-11-02       Impact factor: 3.478

9.  MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies.

Authors:  E Bartoccioni; S Gallucci; F Scuderi; E Ricci; S Servidei; A Broccolini; P Tonali
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

10.  T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8+ T cells.

Authors:  A Bender; N Ernst; A Iglesias; K Dornmair; H Wekerle; R Hohlfeld
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.